<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.dottnet.it/articolo/32543800/sanita-nel-2028-mancheranno-11-miliardi-rispetto-al-fabbisogno</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sanità, nel 2028 mancheranno 11 miliardi rispetto al fabbisogno</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543800-spesasanitaria2.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543721/nsclc-resecabile-chemio-immunoterapia-prima-o-dopo-l-intervento-quale-strada-scegliere-</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>NSCLC resecabile, chemio-immunoterapia prima o dopo l’intervento: quale strada scegliere?</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543721-wavymed-06single-07.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543722/mogad-satralizumab-verso-la-prima-terapia-modificante-fda-concede-la-priority-review</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>MOGAD, satralizumab verso la prima terapia modificante: FDA concede la Priority Review</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543722-wavymed-06single-12.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543801/sanita-nel-2030-mancheranno-11-milioni-di-operatori-nel-mondo</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sanità, nel 2030 mancheranno 11 milioni di operatori nel mondo</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543801-who.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543762/farmacisti-809-specialisti-necessari-nel-2026-214-borse-statali-per-farmacia-ospedaliera</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmacisti, 809 specialisti necessari nel 2026: 214 borse statali per Farmacia ospedaliera</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543762-medical-cross-symbol-cartoon-style1.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543802/sanita-nel-2030-mancheranno-11-milioni-di-operatori-nel-mondo</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sanità, nel 2030 mancheranno 11 milioni di operatori nel mondo</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543802-who.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543803/social-e-adolescenti-negli-usa-arrivano-limiti-e-blocchi-ieud-le-tutele-introdotte-negli-usa-siano-adottate-anche-in-europa-</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Social e adolescenti, negli Usa arrivano limiti e blocchi: IEuD: «Le tutele introdotte negli Usa siano adottate anche in Europa»</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543803-anteprimearticolidottnet-2026-09-21t101745494.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543804/certificati-per-i-cpr-anelli-se-falsi-i-medici-saranno-sanzionati</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Certificati per i Cpr, Anelli: se falsi i medici saranno sanzionati</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543804-rifugiati.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543805/sclerosi-multipla-pediatrica-parere-positivo-del-chmp-per-ocrelizumab-dai-10-anni</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sclerosi multipla pediatrica, parere positivo del CHMP per ocrelizumab dai 10 anni</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543805-handicapped-boy-wheelchair-home.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543806/alzheimer-158-terapie-allo-studio-ma-mancano-pazienti-per-i-trial</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Alzheimer, 158 terapie allo studio ma mancano pazienti per i trial</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543806-alzheimer2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543807/fertilita-il-lazio-apre-alla-crioconservazione-sociale-fino-a-3mila-euro-per-preservare-i-gameti</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Fertilità, il Lazio apre alla crioconservazione sociale: fino a 3mila euro per preservare i gameti</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543807-vertical-closeup-shot-laboratory-worker-incubating-corona-viral-samples.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543809/lo-stress-lascia-il-segno-sul-cuore-danni-invisibili-gia-molti-anni-prima-dei-sintomi</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Lo stress lascia il segno sul cuore: danni invisibili già molti anni prima dei sintomi</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543809-anteprimearticolidottnet-2026-09-21t155822805.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543808/semaglutide-non-solo-peso-e-glicemia-il-farmaco-puo-proteggere-anche-cuore-e-reni</loc>
  <lastmod>2026-09-21T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Semaglutide, non solo peso e glicemia: il farmaco può proteggere anche cuore e reni</news:title>
   <news:publication_date>2026-09-21</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543808-anteprimearticolidottnet-2026-09-21t152716364.png</image:loc>
  </image:image>
 </url>
</urlset>